BizJournals -- Maxygen Inc. and Japanese drug maker Astellas Pharma Inc. will start an R&D joint venture focused on protein drugs but largely spelling the beginning of the end of the Redwood City company as it is known today.
BizJournals -- Maxygen Inc. and Japanese drug maker Astellas Pharma Inc. will start an R&D joint venture focused on protein drugs but largely spelling the beginning of the end of the Redwood City company as it is known today.
